Medtec Pol sp. z o.o.

Retail sale of medical and orthopaedic goods in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-09-19
Share capital
130,000.00 PLN
Activity description

Medtec Pol offers MBST® magnetic resonance therapy, applied at the cellular level for arthrosis, osteoporosis, musculoskeletal injuries, chronic wounds and postoperative conditions. The therapy aims to relieve pain and strengthen articular cartilage, improving mobility and quality of life for patients. The method uses the ASF Open System device and is intended for medical professionals.

Registered address
ul. Wielka 67, 53-340 Wrocław, Poland
Email
Phone
Social media

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$3,240
Profit allocationNo decision
Loans and borrowings$136,733

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 734 days for 2021).

  • 202510/07/2026
  • 202406/10/2025
  • 202318/07/2024
  • 202206/09/2023
  • 202118/07/2024
  • 202011/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Retail trade5,377 / 9,987
Top 54%
City · Wrocław4,024 / 13,650
Top 29%
Voivodeship · Dolnośląskie7,925 / 23,831
Top 33%
Country · Poland102,772 / 297,069
Top 35%

Results vs industry

Revenue
This companyUSD 765.98kMedianUSD 342.26kAverageUSD 2.50m
Net profit
This companyUSD 18.01kMedianUSD 14.40kAverageUSD 165.13k
Operating costs
This companyUSD 743.06kMedianUSD 297.95kAverageUSD 2.26m
Assets
This companyUSD 518.68kMedianUSD 199.40kAverageUSD 1.23m

Offer

Websites

  • mbst-terapia.plMBST Terapia | Zdrowie zaczyna się w komórce | MedTec Pol
    LiteSpeed

Authorized Representatives

Aneta Ewelina Rybus age 46 – President of the Management Board
Małgorzata Joanna Żuchowska age 52 – Vice President

Manner of representation

If a multi-member management board is appointed, each member of the management board is independently authorized to represent the company.

Ownership

OwnerSharesShare valueStake
1,300$17,558.0850%
1,300$17,558.0850%

The articles of association place no restrictions on share transfers.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2025-09-10.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $21,615.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$501
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$635
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$402

Competitors

Name
Biomed Neurotechnologie sp. j.
Permedica Poland sp. z o.o.
Tiba sp. z o.o.
Turbomedic sp. z o.o.
Mimari sp. z o.o.
Amko-MED sp. z o.o.
KLS Martin Poland sp. z o.o.
Laudamed sp. z o.o.
Medical Progress sp. z o.o.
Wimart sp. z o.o.

Change history

DateEvent
2023-01-13Address change
2023-01-13Share capital increase
2019-10-09Share capital increase
2019-10-09PKD change
2019-01-02PKD change

FAQ

Last updated: 2026-07-16